Emre Yekeduz
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
YAU-RCC spotlight: where evidence ends and consensus begins for renal cell carcinoma. Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025.
Journal: Minerva urology and nephrology
Published: July 13, 2026
Role of liquid biopsy in genitourinary (GU) cancers.
Journal: Expert review of molecular diagnostics
Published: May 14, 2026
Sequential use of targeted radioligand therapies in metastatic castration-resistant prostate cancer: A case report and systematic review.
Journal: Critical reviews in oncology/hematology
Published: November 11, 2025
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 31, 2025
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study.
Journal: Immunotherapy
Published: July 04, 2025
Perceptions, Attitudes, and Concerns on Artificial Intelligence Applications in Patients with Cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 23, 2025
Comorbidity Burden and Effectiveness of Immunotherapy in Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: May 06, 2025
Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma.
Journal: BMC cancer
Published: April 27, 2025
The prognostic role of the neutrophil-to-lymphocyte ratio in metastatic urothelial carcinoma.
Journal: Therapeutic advances in medical oncology
Published: April 18, 2025
Last Updated: 09/26/2026